BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaboré EG, Guenancia C, Vaz-Luis I, Di Meglio A, Pistilli B, Coutant C, Cottu P, Lesur A, Petit T, Dalenc F, Rouanet P, Arnaud A, Arsene O, Ibrahim M, Wassermann J, Boileau-Jolimoy G, Martin AL, Lemonnier J, André F, Arveux P. Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study. PLoS Med 2019;16:e1002989. [PMID: 31869400 DOI: 10.1371/journal.pmed.1002989] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Licaj I, Coquan E, Dabakuyo-Yonli TS, Dauchy S, Vaz Luis I, Charles C, Lemogne C, Tredan O, Vanlemmens L, Jouannaud C, Levy C, Rigal O, Fournier M, Petit T, Dalenc F, Rouanet P, Lemonnier J, Everhard S, Cottu P, Joly F. Baseline quality of life and chemotherapy toxicities in patients with early breast cancer. Cancer 2023. [PMID: 36642837 DOI: 10.1002/cncr.34643] [Reference Citation Analysis]
2 Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management. Cancers (Basel) 2023;15. [PMID: 36672434 DOI: 10.3390/cancers15020485] [Reference Citation Analysis]
3 Nyangwara VA, Mazhindu T, Chikwambi Z, Masimirembwa C, Campbell TB, Borok M, Ndlovu N. Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients. Br J Clin Pharmacol 2023. [PMID: 36630266 DOI: 10.1111/bcp.15659] [Reference Citation Analysis]
4 Huang P, Huang J, Zheng Y, Cao W, Shao X, Chen J, Huang Y, Li G, Sharma K, Zhou H, Wang X, Jin H, Chen Z. Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy. Front Pharmacol 2022;13:883600. [DOI: 10.3389/fphar.2022.883600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kogoniya LM, Rusanov MO, Shikina VE. Cardiotoxicity of anticancer drugs and radiotherapy in patients with hematologic malignancies and solid tumors. Onkogematologiâ 2022;17:127-136. [DOI: 10.17650/1818-8346-2022-17-3-127-136] [Reference Citation Analysis]
6 Zhang M, Yang H, Xu C, Jin F, Zheng A. Risk Factors for Anthracycline-Induced Cardiotoxicity in Breast Cancer Treatment: A Meta-Analysis. Front Oncol 2022;12:899782. [DOI: 10.3389/fonc.2022.899782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rusanov МО, Kogoniya LM, Shikina VE. Cardiotoxicity of anthracyclines and targeted anti-HER2/neu therapy in treatment of oncological patients. jour 2022;2:63-67. [DOI: 10.17650/2782-3202-2022-2-2-63-67] [Reference Citation Analysis]
8 Fakhraei R, Peck SS, Abdel-qadir H, Thavendiranathan P, Sabiston CM, Rivera-theurel F, Oh P, Orchanian-cheff A, Lee L, Adams SC. Research Quality and Impact of Cardiac Rehabilitation in Cancer Survivors. JACC: CardioOncology 2022;4:195-206. [DOI: 10.1016/j.jaccao.2022.03.003] [Reference Citation Analysis]
9 Toukabri I, Ben Said A, Hamdi A, Aloulou A, Ben Ayed W, Cherif I, Limayem I. Prevalence and risk factors of trastuzumab induced cardiotoxicity in Tunisian HER2-positive breast cancer patients. J Oncol Pharm Pract 2022;:10781552221076407. [PMID: 35088630 DOI: 10.1177/10781552221076407] [Reference Citation Analysis]
10 Yang Z, Wang W, Wang X, Qin Z. Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer. Front Pharmacol 2021;12:741451. [PMID: 34790121 DOI: 10.3389/fphar.2021.741451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wang D, Yi L, Zhang L, Wang Z. Cause-specific mortality among patients with different molecular subtypes of T1-2N0M0 breast cancer: A population-based study. Medicine (Baltimore) 2021;100:e27605. [PMID: 34713838 DOI: 10.1097/MD.0000000000027605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Qiu S, Zhou T, Qiu B, Zhang Y, Zhou Y, Yu H, Zhang J, Liu L, Yuan L, Yang G, Duan Y, Xing C. Risk Factors for Anthracycline-Induced Cardiotoxicity. Front Cardiovasc Med 2021;8:736854. [PMID: 34660739 DOI: 10.3389/fcvm.2021.736854] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Yin Y, Shen H. Advances in Cardiotoxicity Induced by Altered Mitochondrial Dynamics and Mitophagy. Front Cardiovasc Med 2021;8:739095. [PMID: 34616789 DOI: 10.3389/fcvm.2021.739095] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Vargas-Román K, Cortés-Martín J, Sánchez-García JC, Rodríguez-Blanque R, De La Fuente-Solana EI, Díaz-Rodríguez L. Autonomic Imbalance in Lymphoma Survivors. J Clin Med 2021;10:4391. [PMID: 34640409 DOI: 10.3390/jcm10194391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Jiang W, Zhao W, Huang H. Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy. J Am Coll Cardiol 2021;77:2869-70. [PMID: 34082917 DOI: 10.1016/j.jacc.2020.12.074] [Reference Citation Analysis]
16 Lin YC, Cheng HH, Chen SC, Shen WC, Huang YT. Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer. J Cancer 2021;12:4488-96. [PMID: 34149912 DOI: 10.7150/jca.59133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Cignarella A, Busetto L, Vettor R. Pharmacotherapy of obesity: An update. Pharmacol Res 2021;169:105649. [PMID: 33962014 DOI: 10.1016/j.phrs.2021.105649] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
18 Griggs JJ, Bohlke K, Balaban EP, Dignam JJ, Hall ET, Harvey RD, Hecht DP, Klute KA, Morrison VA, Pini TM, Rosner GL, Runowicz CD, Shayne M, Sparreboom A, Turner S, Zarwan C, Lyman GH. Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update. J Clin Oncol 2021;39:2037-48. [PMID: 33939491 DOI: 10.1200/JCO.21.00471] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
19 Ben Dhia S, Loap P, Loirat D, Vincent-Salomon A, Cao K, Escalup L, Fourquet A, Kirova Y. [Concurrent radiation therapy and dual HER2 blockade in breast cancer: Assessment of toxicity]. Cancer Radiother 2021;25:424-31. [PMID: 33771453 DOI: 10.1016/j.canrad.2020.06.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kolberg HC, Jackisch C, Hurvitz SA, Winstone J, Barham H, Hanes V, Courmier D. Is weight-based IV dosing of trastuzumab preferable to SC fixed-dose in some patients? A systematic scoping review. Breast 2021;57:95-103. [PMID: 33799233 DOI: 10.1016/j.breast.2021.03.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Wang Y, Wen C, Ye J, Huang H, Zhang Y, Yuan H, Yao G, Yu M. [Cytotoxic effect of photodynamic liposome gel combined with trastuzumab on drugresistant breast cancer cells in vitro]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:164-72. [PMID: 33624588 DOI: 10.12122/j.issn.1673-4254.2021.02.02] [Reference Citation Analysis]
22 王 娜. The Evaluation Value of Two-Dimensional Speckle Tracking Layer-Specific Strain Technique for the Assessment of Cardiotoxicity in Breast Cancer Patients after Chemotherapy. MD 2021;11:30-36. [DOI: 10.12677/md.2021.111005] [Reference Citation Analysis]
23 Sandamali JAN, Hewawasam RP, Fernando MACSS, Jayatilaka KAPW, Madurawe RD, Sathananthan PP, Ekanayake U, Horadugoda J. Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients from Southern Sri Lanka: An Echocardiographic Analysis. Biomed Res Int 2020;2020:1847159. [PMID: 33274195 DOI: 10.1155/2020/1847159] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sallustio BC, Boddy AV. Is there scope for better individualisation of anthracycline cancer chemotherapy? Br J Clin Pharmacol. 2021;87:295-305. [PMID: 33118175 DOI: 10.1111/bcp.14628] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
25 Xia W, Zou C, Chen H, Xie C, Hou M. Immune checkpoint inhibitor induces cardiac injury through polarizing macrophages via modulating microRNA-34a/Kruppel-like factor 4 signaling. Cell Death Dis 2020;11:575. [PMID: 32709878 DOI: 10.1038/s41419-020-02778-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
26 Mercurio V, Cuomo A, Cadeddu Dessalvi C, Deidda M, Di Lisi D, Novo G, Manganaro R, Zito C, Santoro C, Ameri P, Spallarossa P, Arboscello E, Tocchetti CG, Penna C. Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC). Antioxidants (Basel) 2020;9:E641. [PMID: 32708201 DOI: 10.3390/antiox9070641] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
27 Denduluri N. Examining Cardiotoxicity With HER2 Therapies. JACC: CardioOncology 2020;2:176-178. [DOI: 10.1016/j.jaccao.2020.05.005] [Reference Citation Analysis]
28 Vuagnat P, Frelaut M, Ramtohul T, Basse C, Diakite S, Noret A, Bellesoeur A, Servois V, Hequet D, Laas E, Kirova Y, Cabel L, Pierga JY, Bozec L, Paoletti X, Cottu P, Bidard FC; Institut Curie Breast Cancer and COVID Group. COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area. Breast Cancer Res 2020;22:55. [PMID: 32460829 DOI: 10.1186/s13058-020-01293-8] [Cited by in Crossref: 64] [Cited by in F6Publishing: 79] [Article Influence: 21.3] [Reference Citation Analysis]
29 L'Abbate S, Russo I, Kusmic C. The role of metabolic diseases in cardiotoxicity associated with cancer therapy: What we know, what we would know. Life Sci 2020;255:117843. [PMID: 32464123 DOI: 10.1016/j.lfs.2020.117843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Vuagnat P, Frelaut M, Ramtohul T, Basse C, Diakite S, Noret A, Bellesoeur A, Servois V, Hequet D, Laas E, Kirova Y, Cabel L, Pierga J, Bozec L, Paoletti X, Cottu P, Bidard F, Institut Curie Breast Cancer and COVID Group. COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area.. [DOI: 10.1101/2020.04.30.20085928] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
31 Obesity increases risk of cardiotoxicity. Reactions Weekly 2020;1786:11-11. [DOI: 10.1007/s40278-020-73485-0] [Reference Citation Analysis]
32 乔 雅. Recent Advances in the Treatment of Cardiac Dysfunction Induced by Antineoplastic Drugs. ACM 2020;10:962-967. [DOI: 10.12677/acm.2020.106146] [Reference Citation Analysis]